Is It Necessary to Use Blood Thinners in IVF Treatment? For How Long?

Short answer: Blood thinners are not required for every IVF patient. Heparin and aspirin are started only when there is a specific indication — thrombophilia, recurrent pregnancy loss, or failed implantation despite good-quality embryos. ESHRE's recurrent implantation failure recommendations do not support routine use in patients without findings, and unnecessary use carries bruising and bleeding risks.

IVF treatment is a process where every stage must be carefully planned. One of the most curious topics in this process is the question, "Do I need to use blood thinner injections?" Some patients think that these drugs are routinely used to increase embryo implantation. However, in reality, not every patient needs blood thinner treatment.

What Are Blood Thinners and Why Are They Used?

Blood thinners (e.g., low-dose heparin or aspirin) are drugs that prevent blood clot formation. Their purpose in IVF treatment is to improve blood circulation within the uterus, increasing the chance of embryo implantation, and to reduce the risk of pregnancy loss in patients with a clotting tendency. Some patients have a congenital or acquired thrombophilia (clotting disorder). In this case, micro-level clots can block the intrauterine vessels, making embryo implantation difficult. It is in these patients that blood thinner treatment is applied under physician supervision.

Who Should Use Them?

Blood thinner treatment is recommended only in specific situations:

• Patients diagnosed with thrombophilia (such as Factor V Leiden, MTHFR mutation, Protein S deficiency),
• Those with a history of recurrent pregnancy loss,
• Cases where implantation could not be achieved despite good quality embryos in previous IVF attempts,
• Women detected with certain immunological problems or blood flow disorders.

If these conditions exist, each patient should be evaluated individually, and the decision to use blood thinners should be made by completing the synthesis of the entire laboratory and evaluation process. However, without any laboratory or clinical findings, using them "just in case" is not right. Because unnecessary use can cause risks such as bruising, nosebleed, and hematoma.

How and For How Long Should They Be Used?

Treatment usually begins close to the day of embryo transfer.

• Low-dose aspirin (e.g., 100 mg/day) may sometimes be started from the stimulation process and sometimes after the transfer.
• Heparin injections (e.g., enoxaparin 40 mg/day) are usually started on the transfer day or the next day.

The duration of the treatment varies according to clinical findings:

• In most cases, up to the 10th–12th week of pregnancy,
• In those diagnosed with thrombophilia, it is continued up to the 20th week.

The dose and duration must be individualized by the physician. Every patient's clotting tendency, weight, liver, and kidney functions are different.

Risks of Unnecessary Use

The thought of "what harm could it do?" is not correct. Unnecessary use of blood thinners can lead to:

• Subcutaneous bruises,
• Prolonged menstrual bleeding,
• Subplacental bleeding during pregnancy.

For this reason, blood thinner treatment is an application that requires a personalized decision.

Conclusion and Recommendation

Blood thinners in IVF treatment can be beneficial when used in the right dose for the right person. However, it is not a routine application for every patient. The most appropriate decision should be made by the physician by evaluating blood tests and previous pregnancy history together. Remember: The main factor that increases embryo implantation is healthy uterine tissue and a balanced hormone environment. Blood thinner treatment is helpful only when necessary.

Frequently Asked Questions

Do blood thinner injections guarantee embryo implantation?

No. Blood thinners do not directly cause implantation. They aim to reduce an obstacle only in patients whose intrauterine blood flow is impaired by a clotting tendency. The main determinants of implantation are embryo quality, the state of the uterine lining and hormonal balance.

Can I use them "just in case" if I have no findings?

This is not advised. Without a laboratory or clinical indication, blood thinners provide no benefit while carrying risks of bruising, prolonged menstrual bleeding, nosebleeds and subplacental bleeding in pregnancy. The decision should follow a joint review of your tests and pregnancy history.

Aspirin or heparin — which one is used?

They are preferred in different situations. Low-dose aspirin (usually 100 mg/day) may begin during ovarian stimulation or after transfer. Low molecular weight heparin injections are most often started on the day of transfer or the following day. The choice depends on the type of clotting disorder identified.

When does blood thinner treatment start?

Treatment usually begins close to the embryo transfer day. In some cases aspirin starts during ovarian stimulation, while heparin frequently begins on transfer day or the day after. The starting point is determined by your physician based on your diagnosis and previous treatment response.

When should I stop taking blood thinners?

Do not stop on your own. In most cases treatment continues until weeks 10–12 of pregnancy; in patients diagnosed with thrombophilia it may extend to week 20. Dose and duration are personalised according to weight, liver and kidney function, and clotting tendency.

This article is for general information purposes and does not replace medical advice. Treatment decisions should be made together with your physician.